Status:
COMPLETED
The Effects of HMB, ATP, and HMB Plus ATP on Muscle Mass, Strength, and Power in Resistance Trained Athletes
Lead Sponsor:
Metabolic Technologies Inc.
Collaborating Sponsors:
University of Tampa
Conditions:
Healthy Experienced Weight Training Males
Eligibility:
MALE
18-30 years
Phase:
NA
Brief Summary
The purpose of this study is to * determine the effects of 12 weeks of HMB free acid gel, ATP, and HMB free acid gel plus ATP supplementation in trained individuals during a periodized training progr...
Detailed Description
In a randomized and double blind study the subjects will consume either placebo supplements, HMB supplement, ATP supplement, or HMB plus ATP supplements for 12 weeks. While consuming the supplements t...
Eligibility Criteria
Inclusion
- Subjects must meet all of the inclusion criteria to participate in the study.
- Have 3 years minimum of free weight training experience
- Can squat a minimum of 1.5 times their bodyweight
- Can bench press a minimum equal to their bodyweight
- Can deadlift a minimum of 1.5 times their bodyweight
- Are free of musculoskeletal injuries
- Have not taken creatine or HMB supplements for 6 weeks
- Are not taking amino acid supplements
- Are not using anabolic or catabolic hormones
- Are not taking medications that may interfere with study measurements
- Are not users of tobacco products
- All candidates meeting any one of the exclusion criteria will not be enrolled into the study.
- Do not have 3 years minimum of free weight training experience
- Can not squat a minimum of 1.5 times their bodyweight
- Can not bench press a minimum equal to their bodyweight
- Can not deadlift a minimum of 1.5 times their bodyweight
- Are not free of musculoskeletal injuries
- Have not taken creatine or HMB supplements in the past 6 weeks
- Are currently taking amino acid supplements
- Are using anabolic or catabolic hormones
- Are taking medications that may interfere with study measurements
- Use of tobacco products
Exclusion
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT01508338
Start Date
January 1 2012
End Date
October 1 2012
Last Update
August 1 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Tampa
Tampa, Florida, United States, 33606